Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Whole-cell allogenic vaccines for cancer. Acquired by VaxOnco Inc.Funding
Funding rounds
(1 May 2006)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
3i Group PLC | Major, long established, quoted private equity investor | United Kingdom |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
3i Group PLC Major, long established, quoted private equity investor |
Series C | ||
Excalibur Fund Managers Ltd |
+44 (20) 7887-7642 |
N/A |